An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

This study has been terminated.

( Recruitment stopped according to early stopping rule (by protocol) )

Study NCT00597116 Information provided by AstraZeneca

First Received: January 9, 2008 Last Updated: October 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	January 2010
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)